Targeted proteomics for cancer biomarker verification and validation

Area of Science:

• Proteomics
• Biomarker Discovery
• Mass Spectrometry

Background:

• Candidate cancer biomarker proteins require robust verification and validation.
• Existing methods like ELISA have limitations in speed and specificity for modifications.

Purpose of the Study:

• To review the technical principles of targeted proteomics for cancer biomarker verification and validation.
• To highlight the advantages of targeted proteomics in the cancer biomarker pipeline.

Main Methods:

• Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is the core technology.
• Internal standard peptides are used for absolute protein quantification.

Main Results:

• Targeted proteomics allows rapid method development and simultaneous measurement of multiple proteins.
• High specificity for detecting protein modifications is achieved.
• Absolute quantification is crucial for establishing diagnostic cut-off values.

Conclusions:

• Targeted proteomics facilitates the transition of cancer biomarkers from discovery to clinical validation.
• It accelerates the overall cancer biomarker development pipeline.
• Understanding its principles is key for effective utilization.